| Mr Paul Raymond Szedziewski, LCSW | |
|
3970 N Oakland Ave Suite 502, Milwaukee, WI 53211 | |
| (414) 264-4343 | |
| (414) 332-8596 |
| Full Name | Mr Paul Raymond Szedziewski |
|---|---|
| Gender | Male |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 3970 N Oakland Ave Suite 502, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093881625 | NPI | - | NPPES |
| 39621200 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 356 (Wisconsin) | Primary |
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 13214 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Paul Raymond Szedziewski, LCSW 3970 N Oakland Ave Suite 502, Milwaukee, WI 53211 Ph: (414) 264-4343 | Mr Paul Raymond Szedziewski, LCSW 3970 N Oakland Ave Suite 502, Milwaukee, WI 53211 Ph: (414) 264-4343 |
News Archive
A U.S. Surgeon General's report due to be released March 8 will come down hard on states that have cut anti-smoking funds in tough fiscal times, said Terry Pechacek, who oversees the report as director for Science in the Office on Smoking and Health at the Centers for Disease Control and Prevention. The report can't result in sanctions, but it has proven to move public opinion in the past to force changes by tobacco companies in how they sell cigarettes, how states fund efforts and how the federal government regulates the trade.
Researchers at the University of California, San Diego School of Medicine, the National Institutes of Health and the Mayo Clinic have published promising results of a clinical study using an experimental anti-fibrotic and anti-inflammatory drug called pirfenidone to treat patients with diabetic nephropathy. Their study will be published in the April 21 issue of the Journal of the American Society of Nephrology.
Scientists from Imperial College London are developing technology that could ultimately sequence a person's genome in mere minutes, at a fraction of the cost of current commercial techniques.
An asthma intervention program applied during the first year of life significantly reduced the prevalence of asthma in high risk children at 7 years of age, according to a new study featured on the online version of the Journal of Allergy & Clinical Immunology (JACI). The JACI is the peer-reviewed journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).
Above average or high BMI - often linked to cancers, diabetes, cardiovascular and other diseases - may in some cases improve the chance of survival among certain cancers, new research from Flinders University indicates.
› Verified 1 days ago